At-home genetic testing market seen reaching $8.29 billion by 2030

The at-home genetic testing market is projected to grow from $4.02 billion in 2025 to $8.29 billion by 2030, according to The Business Research Company. Growth is being fueled by telehealth adoption, falling sequencing costs and wider use of direct-to-consumer health kits.

Why it matters: - The at-home genetic testing market is moving from a niche consumer product to a broader digital health tool. - Wider use of home DNA tests could expand access to ancestry, health-risk and preventive-care insights. - The market’s growth may also shape how telehealth providers use genetic data in virtual care.

What happened: - The Business Research Company said the at-home genetic testing market will rise from $4.02 billion in 2025 to $4.66 billion in 2026. - The company projected the market will reach $8.29 billion by 2030. - The forecast implies a 15.8% compound annual growth rate in the near term and 15.5% through 2030. - The report was published in London on Nov. 4, 2026.

The details: - At-home genetic testing, also known as direct-to-consumer genetic testing, lets users collect DNA samples at home, often with saliva or cheek swabs. - The tests can provide information on ancestry, health risks, physical traits and carrier status for inherited conditions. - Growth drivers include rising demand for personalized health insights, lower genetic sequencing costs, more online health platforms and greater awareness of hereditary disease risks. - The report also points to broader acceptance of digital healthcare solutions and easier access to home sampling kits. - Future growth is expected to come from more genetic data being used in digital health platforms, stronger preventive-care demand, personalized nutrition and fitness planning, clearer DTC testing rules and better genomic data analytics. - Key trends include more DTC genetic health kit use, stronger interest in ancestry and ethnicity testing, wider use of pharmacogenomics, more personalized wellness insights and more focus on data privacy and informed consent. - The report says telehealth adoption is a major driver because remote care can use genetic data to support customized treatment plans and chronic disease management. - Australian Bureau of Statistics data showed 22.5% of Australians used telehealth in 2024-25, and 90.3% of users said they would use it again, up from 89.2% a year earlier. - North America held the largest regional share of the market in 2025. - Asia-Pacific is forecast to post the fastest growth over the coming years. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The market forecast suggests consumers are becoming more comfortable making health decisions from at-home test results. - Telehealth growth may be reinforcing demand because virtual care creates a use case for genetic information without an in-person visit. - Privacy and consent are emerging as competitive and regulatory pressure points as more consumers share sensitive genetic data.

What's next: - The market’s next phase will likely depend on how quickly telehealth, preventive care and personalized wellness platforms integrate genetic data. - Regulatory clarity around direct-to-consumer testing could shape adoption and product design. - The Asia-Pacific region is expected to become the key growth engine as the market expands toward 2030. - The full report is available here, and a sample can be downloaded here.